02.09.2015 Views

Acute Hepatitis Including Acute Liver Failure

Acute Hepatitis Including Acute Liver Failure - Virtual Pathology at ...

Acute Hepatitis Including Acute Liver Failure - Virtual Pathology at ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Acute</strong> <strong>Hepatitis</strong><br />

<strong>Including</strong> <strong>Acute</strong> <strong>Liver</strong> <strong>Failure</strong><br />

Stefan Hübscher, School of Cancer Sciences, University of Birmingham.<br />

David Mutimer, <strong>Liver</strong> Unit, Queen Elizabeth Hospital, Birmingham


<strong>Acute</strong> liver failure<br />

<strong>Acute</strong> <strong>Liver</strong> Injury


<strong>Acute</strong> <strong>Liver</strong> <strong>Failure</strong> (ALF)<br />

FHF and LOHF<br />

• FHF : fulminant hepatic failure<br />

“The development of encephalopathy within 8<br />

weeks of the onset of symptoms, without<br />

previous liver disease.”<br />

• LOHF : late onset hepatic failure<br />

“Encephalopathy appears after 8 weeks, but<br />

within 6 months of symptom onset.”<br />

‣ subacute hepatic necrosis<br />

‣ subacute hepatic failure


<strong>Acute</strong> <strong>Liver</strong> <strong>Failure</strong> (ALF)<br />

FHF and LOHF<br />

• FHF<br />

‣ paracetamol poisoning<br />

‣ coagulopathy + +<br />

‣ cerebral oedema + +<br />

‣ hypoglycaemia<br />

‣ may present before jaundice<br />

‣ potential for recovery with conservative care<br />

• LOHF<br />

‣ seronegative hepatitis (non-A, non-B)<br />

‣ coagulopathy +<br />

‣ ascites +<br />

‣ jaundice ++<br />

‣ renal failure<br />

‣ conservative care fails, transplant indicated


<strong>Acute</strong> <strong>Liver</strong> <strong>Failure</strong> Admissions<br />

Birmingham <strong>Liver</strong> Unit 1987-2007<br />

1000<br />

800<br />

600<br />

400<br />

200<br />

0<br />

Seronegative<br />

AFLP/HELLP<br />

Other drug/toxin<br />

Miscellaneous<br />

POD<br />

Viral<br />

AVOD<br />

Wilsons<br />

Budd Chiari


<strong>Acute</strong> <strong>Liver</strong> Injury<br />

Patient Management<br />

• Aetiology<br />

• Severity<br />

• Prognosis


<strong>Acute</strong> <strong>Liver</strong> Injury<br />

Establishing the Aetiology<br />

History<br />

• drug exposure<br />

‣ prescription<br />

‣ non-prescription<br />

‣ herbal<br />

• psychiatric and psychosocial issues<br />

• exposure to hepatitis viruses<br />

‣ travel (hepatitis A or E)<br />

‣ sex (hepatitis B)<br />

‣ blood exposure (hepatitis C or B)<br />

Examination<br />

• absence of signs of chronic liver disease<br />

• liver size


<strong>Acute</strong> <strong>Liver</strong> Injury<br />

Establishing the Aetiology<br />

Blood tests<br />

• routine biochemistry<br />

‣hyperacute (high transaminases, lower bilirubin)<br />

• paracetamol, ischaemia, hepatitis B<br />

‣subacute (lower transaminases, higher bilirubin)<br />

• seronegative hepatitis<br />

‣Wilson’s disease (low alkaline phosphatase)<br />

• paracetamol detection<br />

• viral serology<br />

‣IgM antibodies to HAV, HBV, HEV<br />

• liver immunology<br />

‣autoantibodies, immunoglobulins


<strong>Acute</strong> <strong>Liver</strong> Injury<br />

Establishing the Aetiology<br />

Imaging<br />

• ultrasound<br />

‣ liver size and texture<br />

‣ spleen size<br />

‣ ascites<br />

‣ oedematous gall bladder<br />

‣ infiltration<br />

• ? CT scan<br />

Biopsy<br />

• how will the histology influence management?<br />

• problems<br />

• bleeding<br />

• cerebral oedema<br />

• misinterpretation of histology (by the pathologist)<br />

• clinician over-reliance on histological diagnosis<br />

• delays definitive treatment


<strong>Acute</strong> <strong>Liver</strong> Injury<br />

Establishing the Severity & Prognosis<br />

• Aetiology<br />

‣ paracetamol poisoning has unique prognostic criteria<br />

‣ seronegative hepatitis has poor prognosis<br />

• Duration of illness<br />

• Clinical features<br />

‣ shrinking liver<br />

‣ ascites<br />

• Biochemistry limited value<br />

• Coagulation important


Case 1


Case 1<br />

• 52 year old Caucasian male<br />

• GP referral to surgeons with “obstructive jaundice”<br />

• US and MRCP (stones in gall bladder, spleen 13 cm)<br />

• liver biochemistry<br />

• refer to physicians (seen 2 weeks later in clinic)<br />

• ALT 1263, bilirubin 250, INR 1.1 (and stable for 2 weeks)<br />

• viral serology negative<br />

• immunology<br />

• antinuclear antibody and anti smooth muscle antibody positive<br />

• slightly elevated immunoglobulins<br />

• diagnosis: aetiology and severity?<br />

• acute autoimmune hepatitis (can be underlying chronic damage)<br />

• no evidence of liver failure (not incipient)<br />

• liver biopsy


<strong>Liver</strong> Biopsy in <strong>Acute</strong> <strong>Hepatitis</strong><br />

Histological Approach<br />

1. Is this acute or chronic damage?<br />

2. How severe is the damage?<br />

3. What is the cause?


Case 1


Case 1


Case 1


Case 1 - ductular reaction<br />

CK7 immunostaining


Case 1


Case 1


Case 1


Case 1 (PAS-diastase)


Case 1 (PAS-diastase)


<strong>Acute</strong> <strong>Hepatitis</strong><br />

Hepatocyte Proliferation (Ki 67 immunostaining)


Case 1 (Perl’s)


Case 1 (HVG)


Case 1<br />

Histological Findings<br />

• Portal inflammation<br />

– mainly mononuclear with plasma cells<br />

• Bile ductular reaction<br />

• Spotty lobular inflammation, associated with<br />

– Ballooning<br />

– Acidophil body formation<br />

– Lobular disarray<br />

– Small foci of confluent necrosis<br />

– Bilirubinostasis (mild)


Case 1<br />

Diagnosis<br />

• <strong>Acute</strong> hepatitis with spotty necrosis and focal<br />

confluent necrosis<br />

• In keeping with autoimmune hepatitis


Autoimmune <strong>Hepatitis</strong> - <strong>Acute</strong> Presentation<br />

Incidence & Diagnostic Criteria<br />

30- 40% of cases present as acute hepatitis /acute liver failure<br />

(Czaja & Freese 2002, Lohse 2011)<br />

Increasing prevalence of AIH as a cause for acute liver failure<br />

(Fujiwara 2011)<br />

• ? May reflect improved recognition<br />

Autoantibodies unreliable in the diagnosis of acute AIH<br />

• Autoantibodies and hypergammaglobulinaemia may not be present at the time<br />

of presentation with acute AIH (Lohse 2011)<br />

• Autoantibodies present in up to 40% of patients with other causes of acute<br />

liver failure - e.g viral or drug-induced (Bernal 2007, Reuben 2010)


Autoimmune <strong>Hepatitis</strong> - <strong>Acute</strong> Presentation<br />

Histological Features<br />

<strong>Acute</strong> presentation of chronic liver disease<br />

• 14-35% have features of chronic hepatitis (Fujiwara 2011,<br />

Yasui 2011)<br />

• 10-95% have bridging fibrosis or cirrhosis (Nikias 1994,<br />

Burgart 1995, Miyake 2010, Fujiwara 2011)


Autoimmune <strong>Hepatitis</strong> - <strong>Acute</strong> Presentation<br />

Histological Features<br />

<strong>Acute</strong> hepatitis (with no signs of chronic liver disease)<br />

(Hofer 2006, Te 1997, Singh 2002, Hofer 2006, Ichai 2007, Miyake 2010, Fujiwara 2011,<br />

Stravitz 2011, Susuki 2011, Yasui 2011)<br />

– Classical features of acute lobular hepatitis<br />

– Mainly centrilobular distribution (central perivenulitis)<br />

• Often associated with centrilobular necrosis<br />

– Some cases initially have little or no portal inflammation, before<br />

subsequently progressing to more classical features of chronic AIH


Case 1- outcome<br />

• Treatment with corticosteroids and azathioprine<br />

• Prompt resolution of liver dysfunction<br />

• Negativity of autoantibodies<br />

• Reduction of immunosuppression<br />

‣ mild biochemical relapse<br />

‣ reappearance of autoantibodies


Case 2<br />

• 67 year old Caucasian male<br />

• 1 to 2 week history of jaundice and abdominal distension<br />

• ALT 1011, bilirubin 220, INR 2.0<br />

• viral serology negative<br />

• autoantibodies negative, immunoglobulins normal<br />

• US scan<br />

‣ small liver<br />

‣ ascites ++<br />

‣ spleen not enlarged<br />

• Diagnosis: aetiology and severity<br />

‣ acute seronegative hepatitis<br />

‣ severe (small liver with ascites)<br />

‣ poor prognosis for recovery<br />

• <strong>Liver</strong> biopsy


Case 2<br />

LIVER BIOPSY


<strong>Liver</strong> Biopsy – Case 2<br />

Histological Findings<br />

• Recent panacinar necrosis (multi-acinar necrosis)<br />

– Periportal ductular reaction<br />

– No surviving hepatocytes<br />

Comment<br />

• Likely to be a manifestation of severe acute hepatitis<br />

• No obvious aetiological pointers


Case 2 – outcome<br />

• Mild encephalopathy 1 week post-admission<br />

• Listed “superurgent” for transplantation<br />

• Transplanted<br />

• Excellent recovery<br />

‣ no early recurrence<br />

• Continues immunosuppression


Case 2<br />

HEPATECTOMY SPECIMEN


Case 2. Macroscopic Appearances<br />

Shrunken liver, weight 700g. Wrinkled capsular surface


Case 2<br />

Macroscopic Appearances


Could this be cirrhotic?


Recent Post-Necrotic Collapse versus Longstanding Fibrosis<br />

Use Of Connective Tissue Stains<br />

Stain<br />

Material<br />

Demonstrated<br />

Distribution In<br />

Normal <strong>Liver</strong><br />

Changes In <strong>Liver</strong> Disease<br />

Reticulin<br />

Type III collagen<br />

fibres<br />

Portal tracts,<br />

hepatic sinusoids<br />

Collapse of reticulin<br />

framework in areas of<br />

recent liver cell necrosis.<br />

(few days)<br />

Haematoxylin<br />

Van Gieson<br />

Type I collagen fibres<br />

Portal tracts, walls<br />

of hepatic veins<br />

Increased in hepatic fibrosis<br />

(weeks/months)<br />

Orcein Elastic fibres Portal tracts,<br />

walls of hepatic<br />

veins<br />

Found in long-standing<br />

fibrosis/cirrhosis<br />

(months/years)


Other Changes Seen in Areas of Parenchymal Necrosis<br />

Congestion<br />

May suggest a vascular problem – e.g. venous outflow obstruction


Other Changes Seen in Areas of Parenchymal Necrosis<br />

PAS-diastase CD 68<br />

Ceroid Pigment Laden Macrophages


Hepatectomy Specimen – Case 2<br />

Histological Findings<br />

• Large areas of panacinar necrosis (multi-acinar necrosis)<br />

– Periportal ductular reaction<br />

– Inflammation of hepatic veins<br />

• Surviving areas of liver parenchyma<br />

– Nodular regeneration<br />

– Severe bilirubinostasis<br />

– Zonal/bridging necrosis<br />

– Little inflammation


Diagnosis<br />

Hepatectomy Specimen – Case 2<br />

• Severe acute hepatitis with multiacinar necrosis<br />

(submassive hepatic necrosis)<br />

• No strong aetiological pointers ( “seronegative<br />

hepatitis”)


Role of <strong>Liver</strong> Biopsy in <strong>Acute</strong> <strong>Hepatitis</strong><br />

• Many of the classical morphological studies of acute hepatitis were carried<br />

out before the main causes had been discovered<br />

• Most cases of acute hepatitis now diagnosed on the basis of clinical,<br />

biochemical and serological findings and liver biopsy is rarely indicated<br />

• <strong>Liver</strong> biopsy may still be carried out in cases where the clinical presentation<br />

is atypical or the cause is uncertain<br />

– Confirm diagnosis of acute hepatitis<br />

– Determine disease severity<br />

– Identify possible aetiological factors (including cases of acute liver injury not<br />

related to hepatitis)


<strong>Liver</strong> Biopsy in <strong>Acute</strong> <strong>Hepatitis</strong><br />

Histological Approach<br />

1. Is this acute or chronic damage?<br />

• severe acute hepatitis versus<br />

• decompensated chronic liver disease<br />

• acute exacerbation of chronic liver disease (e.g. autoimmune hepatitis,<br />

hepatitis A/E superimposed on underlying cirrhosis)<br />

2. How severe is the damage?<br />

3. What is the cause?


<strong>Acute</strong> versus Chronic Damage<br />

Severe <strong>Acute</strong> <strong>Hepatitis</strong> (e.g. case 2)<br />

• Areas of bridging necrosis & nodular regeneration can resemble changes occurring<br />

in cirrhosis<br />

• Areas of multiacinar necrosis can resemble inflamed fibrous septa in cirrhosis<br />

<strong>Acute</strong> versus Chronic Damage - Helpful pointers<br />

• Clinical context<br />

• Identification of normal vascular relationships<br />

• Use of connective tissue stains to determine age of lesions


<strong>Liver</strong> Biopsy in <strong>Acute</strong> <strong>Hepatitis</strong><br />

Histological Approach<br />

1. Is this acute or chronic damage?<br />

2. How severe is the damage?<br />

3. What is the cause?


<strong>Liver</strong> Cell Death in <strong>Acute</strong> <strong>Hepatitis</strong><br />

Pattern of Cell Death<br />

Histological Features<br />

Spotty necrosis<br />

Apoptosis of individual hepatocytes (acidophil bodies)<br />

Confluent necrosis<br />

(zone 3)<br />

Bridging necrosis<br />

Panacinar necrosis<br />

Loss of groups of adjacent liver cells<br />

Confluent necrosis linking vascular structures<br />

(central-central or central-portal bridging)<br />

Loss of hepatocytes in an entire acinus<br />

Multiacinar necrosis<br />

Panacinar necrosis involving several adjacent acini<br />

• Apoptosis > necrosis (in mild forms)<br />

• Severe necro-inflammatory lesions uneven in distribution<br />

‣ Sampling variability in liver biopsies<br />

‣ Extent of hepatocyte necrosis predictive of poor outcome in some studies (Katoonizadeh<br />

2006, Miraglia 2006, Rastogi 2011)


<strong>Liver</strong> Biopsy in <strong>Acute</strong> <strong>Hepatitis</strong><br />

Histological Approach<br />

1. Is this acute or chronic damage?<br />

2. How severe is the damage?<br />

3. What is the cause?


<strong>Acute</strong> <strong>Hepatitis</strong> - Common Causes<br />

1. Viral<br />

• <strong>Hepatitis</strong> viruses – A,B,C,D, E<br />

• Other viruses – e.g. CMV, EBV<br />

2. Drugs<br />

3. Autoimmune<br />

4. Unknown<br />

• Seronegative hepatitis (“non-A, non-B, non-C hepatitis”)<br />

• Accounts for 40% of patients in the U.K presenting with<br />

severe acute hepatitis leading to acute liver failure (Ichai 2008,<br />

Bernal 2010)


<strong>Acute</strong> <strong>Hepatitis</strong> - Aetiological Considerations<br />

<strong>Liver</strong> biopsy rarely identifies a previously unsuspected aetiology<br />

• Biopsies mostly obtained from people in whom main recognised causes have been<br />

excluded (“seronegative hepatitis”)<br />

• Biopsy sometimes provides pointers to a previously unsuspected aetiology<br />

Aetiology<br />

Suggestive Histological features<br />

Drugs • Disproportionately severe / well-circumscribed necrosis<br />

(relatively little inflammation – lobular and/or portal)<br />

• Unusual patterns of necrosis - e.g periportal (zone 1) necrosis<br />

• Unusually prominent cholestasis<br />

• Eosinophils, granulomas<br />

Autoimmune<br />

hepatitis<br />

(Abe 2007, Fujiwara 2008,<br />

Stravitz 2011, Yasui 2011)<br />

• Plasma cell rich portal infiltrate (also seen in hepatitis A)<br />

• Prominent periportal inflammation (interface hepatitis)<br />

• Lymphoid aggregates<br />

• Prominent centrilobular inflammation (“central perivenulitis”)


<strong>Acute</strong> <strong>Hepatitis</strong> - Aetiological Considerations<br />

<strong>Liver</strong> biopsy may identify a cause of acute liver injury not due to acute hepatitis<br />

• Decompensated chronic liver disease (e.g. Wilson’s disease)<br />

• Another cause of acute liver damage (e.g. ischaemic hepatitis, severe<br />

alcoholic hepatitis, paracetamol toxicity)<br />

• Hepatic infiltration (usually lymphoma, less commonly carcinoma)<br />

– <strong>Liver</strong> usually enlarged


Saturday 22 October 2011

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!